RMDResMed

Median target
$235
calls from the last 12 months
Implied return
+2.9%
median target vs. price
Coverage
16 analysts · 16 calls
updated in the last 12 months
Consensus
7/9/0+7 net
Buy / Hold / Sell

Which analysts are behind RMD's consensus?

See every current rating, price target and the analysts' track records for ResMed — plus the full analyst rankings, firm analytics and screener.

The consensus above reflects 16 analysts with calls on RMD updated in the last 12 months. Implied return is the move implied if the consensus target were hit. These are forward-looking predictions, not realized returns. Per-analyst ratings and track records are a Premium feature.

RMD elsewhere on AnalystEdge

The most recent congressional, executive-branch and insider filings matched to this ticker. Matched by ticker symbol — occasional mismatches are possible. Not investment advice.

Trending today: not in any of today's trending tables (Gaining attention, Losing attention, Most followed)

DateSourceWhoActionDetailAmount
2026-09-08InsidersFarrell Michael J.Chairman and CEOInsider sale5.0K sh @ $222.44 · planned trade$1.1M
2026-09-02InsidersFarrell Peter CDirectorInsider sale970 sh @ $234.73 · planned trade$228K
2026-08-07InsidersFarrell Michael J.Chairman and CEOInsider sale5.0K sh @ $205.69 · planned trade$1.0M
2026-08-05InsidersFarrell Peter CDirectorInsider sale8.0K sh @ $225.00 · planned trade$1.8M
2026-04-28ExecutiveTrump, Donald JPresidentSaleResmed Inc$1,001 - $15,000
2026-04-27ExecutiveTrump, Donald JPresidentPurchaseResmed Inc$15,001 - $50,000
2026-03-11ExecutiveTrump, Donald JPresidentTransactionRESMED INC$15,001 - $50,000
2025-10-31ExecutiveTrump, Donald JPresidentPurchaseRESMED INC$1,001 - $15,000
2025-10-29ExecutiveTrump, Donald JPresidentSaleRESMED INC$15,001 - $50,000
2025-10-10ExecutiveTrump, Donald JPresidentPurchaseRESMED INC$1,001 - $15,000

More: congressional trades on RMD · insider activity · executive branch · trending